Last Updated: November 9, 2026

List of Excipients in API olmesartan medoxomil and hydrocholorothiazide

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing olmesartan medoxomil and hydrocholorothiazide

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204	CELLULOSE, MICROCRYSTALLINE
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204	FERRIC OXIDE RED
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204	FERRIC OXIDE YELLOW
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204	HYDROXYPROPYL CELLULOSE
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204	HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for olmesartan medoxomil and hydrocholorothiazide

Excipient focus: CELLULOSE, MICROCRYSTALLINE

olmesartan medoxomil and hydrocholorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

olmesartan medoxomil and hydrocholorothiazide drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

olmesartan medoxomil and hydrocholorothiazide drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

olmesartan medoxomil and hydrocholorothiazide drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

olmesartan medoxomil and hydrocholorothiazide drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

olmesartan medoxomil and hydrocholorothiazide drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

olmesartan medoxomil and hydrocholorothiazide drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

olmesartan medoxomil and hydrocholorothiazide drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

olmesartan medoxomil and hydrocholorothiazide drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

olmesartan medoxomil and hydrocholorothiazide drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Micro Labs Limited	olmesartan medoxomil and hydrocholorothiazide	42571-204
>Company	>Ingredient	>NDC

olmesartan medoxomil and hydrocholorothiazide drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.